newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Announces 1-for-35 Reverse Stock Split

MALVERN, Pa., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that the Company's Board of Directors has app